Fulcrum Therapeutics (FULC) Leases: 2022-2025
Historic Leases for Fulcrum Therapeutics (FULC) over the last 4 years, with Sep 2025 value amounting to $4.6 million.
- Fulcrum Therapeutics' Leases fell 23.41% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 23.41%. This contributed to the annual value of $5.7 million for FY2024, which is 20.79% down from last year.
- As of Q3 2025, Fulcrum Therapeutics' Leases stood at $4.6 million, which was down 7.33% from $5.0 million recorded in Q2 2025.
- Fulcrum Therapeutics' 5-year Leases high stood at $10.4 million for Q1 2022, and its period low was $4.6 million during Q3 2025.
- Over the past 3 years, Fulcrum Therapeutics' median Leases value was $6.4 million (recorded in 2024), while the average stood at $6.5 million.
- Data for Fulcrum Therapeutics' Leases shows a maximum YoY declined of 23.41% (in 2025) over the last 5 years.
- Quarterly analysis of 4 years shows Fulcrum Therapeutics' Leases stood at $9.1 million in 2022, then declined by 20.82% to $7.2 million in 2023, then decreased by 20.79% to $5.7 million in 2024, then decreased by 23.41% to $4.6 million in 2025.
- Its last three reported values are $4.6 million in Q3 2025, $5.0 million for Q2 2025, and $5.3 million during Q1 2025.